Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive Podcast
Tearing Down Silos to Usher Innovative Medicines to Patients Faster
22 minutes Posted Mar 16, 2023 at 1:00 pm.
0:00
22:00
Download MP3
Show notes
Cathi Ahearn is a seasoned biotechnology leaders with formative stints at Genentech, Roche, and now at Bristol Myers Squibb, as SVP of worldwide commercial portfolio strategy. Cathi is focused on one goal: shortening the path between creating medical innovation and getting that innovation to patients. Cathi chats with senior editor at Pharmaceutical Executive about her experiences in the past 20+ years and most importantly, the power of cross-functional collaboration, bringing different teams together and tearing down silos that limit the impact new innovations can have for patients.